These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 1327907

  • 21. Optimized Procedure for Recovering HIV-1 Protease (C-SA) from Inclusion Bodies.
    Maseko SB, Govender D, Govender T, Naicker T, Lin J, Maguire GEM, Kruger HG.
    Protein J; 2019 Feb; 38(1):30-36. PubMed ID: 30666487
    [Abstract] [Full Text] [Related]

  • 22. Chemical synthesis of a biotinylated derivative of the simian immunodeficiency virus protease. Purification by avidin affinity chromatography and autocatalytic activation.
    Tomasselli AG, Bannow CA, Deibel MR, Hui JO, Zurcher-Neely HA, Reardon IM, Smith CW, Heinrikson RL.
    J Biol Chem; 1992 May 25; 267(15):10232-7. PubMed ID: 1587812
    [Abstract] [Full Text] [Related]

  • 23. Molecular evolution of the human and simian immunodeficiency viruses.
    Yokoyama S.
    Mol Biol Evol; 1988 Nov 25; 5(6):645-59. PubMed ID: 2464734
    [Abstract] [Full Text] [Related]

  • 24. Human immunodeficiency virus protease ligand specificity conferred by residues outside of the active site cavity.
    Hoog SS, Towler EM, Zhao B, Doyle ML, Debouck C, Abdel-Meguid SS.
    Biochemistry; 1996 Aug 13; 35(32):10279-86. PubMed ID: 8756683
    [Abstract] [Full Text] [Related]

  • 25. Domain flexibility in retroviral proteases: structural implications for drug resistant mutations.
    Rose RB, Craik CS, Stroud RM.
    Biochemistry; 1998 Feb 24; 37(8):2607-21. PubMed ID: 9485411
    [Abstract] [Full Text] [Related]

  • 26. Purification and characterization of naturally occurring HIV-1 (South African subtype C) protease mutants from inclusion bodies.
    Maseko SB, Natarajan S, Sharma V, Bhattacharyya N, Govender T, Sayed Y, Maguire GE, Lin J, Kruger HG.
    Protein Expr Purif; 2016 Jun 24; 122():90-6. PubMed ID: 26917227
    [Abstract] [Full Text] [Related]

  • 27. Use of protein unfolding studies to determine the conformational and dimeric stabilities of HIV-1 and SIV proteases.
    Grant SK, Deckman IC, Culp JS, Minnich MD, Brooks IS, Hensley P, Debouck C, Meek TD.
    Biochemistry; 1992 Oct 06; 31(39):9491-501. PubMed ID: 1390732
    [Abstract] [Full Text] [Related]

  • 28. Alternative native flap conformation revealed by 2.3 A resolution structure of SIV proteinase.
    Wilderspin AF, Sugrue RJ.
    J Mol Biol; 1994 May 27; 239(1):97-103. PubMed ID: 8196050
    [Abstract] [Full Text] [Related]

  • 29. Interactions of substrates and inhibitors with a family of tethered HIV-1 and HIV-2 homo- and heterodimeric proteinases.
    Griffiths JT, Tomchak LA, Mills JS, Graves MC, Cook ND, Dunn BM, Kay J.
    J Biol Chem; 1994 Feb 18; 269(7):4787-93. PubMed ID: 8106448
    [Abstract] [Full Text] [Related]

  • 30. Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures.
    Tong L, Pav S, Pargellis C, Dô F, Lamarre D, Anderson PC.
    Proc Natl Acad Sci U S A; 1993 Sep 15; 90(18):8387-91. PubMed ID: 8378311
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of the aspartic proteinase from HIV-2.
    Richards AD, Broadhurst AV, Ritchie AJ, Dunn BM, Kay J.
    FEBS Lett; 1989 Aug 14; 253(1-2):214-6. PubMed ID: 2668032
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Reversible oxidation of HIV-2 protease.
    Davis DA, Newcomb FM, Moskovitz J, Fales HM, Levine RL, Yarchoan R.
    Methods Enzymol; 2002 Aug 14; 348():249-59. PubMed ID: 11885278
    [No Abstract] [Full Text] [Related]

  • 34. Purification and antigenicity of two recombinant forms of Boophilus microplus yolk pro-cathepsin expressed in inclusion bodies.
    Leal AT, Pohl PC, Ferreira CA, Nascimento-Silva MC, Sorgine MH, Logullo C, Oliveira PL, Farias SE, da Silva Vaz I, Masuda A.
    Protein Expr Purif; 2006 Jan 14; 45(1):107-14. PubMed ID: 16122942
    [Abstract] [Full Text] [Related]

  • 35. Crystallization and preliminary X-ray investigation of recombinant simian immunodeficiency virus proteinase.
    Wilderspin AF, Sugrue RJ.
    J Mol Biol; 1993 Jun 20; 231(4):1139-42. PubMed ID: 8515473
    [Abstract] [Full Text] [Related]

  • 36. New aspartic proteinase of Ulysses retrotransposon from Drosophila virilis.
    Volkov DA, Dergousova NI, Rumsh LD.
    Biochemistry (Mosc); 2004 Jun 20; 69(6):697-701. PubMed ID: 15236611
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication.
    Kuwata T, Igarashi T, Ido E, Jin M, Mizuno A, Chen J, Hayami M.
    J Gen Virol; 1995 Sep 20; 76 ( Pt 9)():2181-91. PubMed ID: 7561755
    [Abstract] [Full Text] [Related]

  • 39. Hydrolysis of synthetic chromogenic substrates by HIV-1 and HIV-2 proteinases.
    Phylip LH, Richards AD, Kay J, Kovalinka J, Strop P, Blaha I, Velek J, Kostka V, Ritchie AJ, Broadhurst AV.
    Biochem Biophys Res Commun; 1990 Aug 31; 171(1):439-44. PubMed ID: 2203349
    [Abstract] [Full Text] [Related]

  • 40. The simian immunodeficiency virus envelope open reading frame located after the termination codon is expressed in vivo in infected animals.
    Franchini G, Kanki PJ, Bosch ML, Fargnoli K, Wong-Staal F.
    AIDS Res Hum Retroviruses; 1988 Aug 31; 4(4):251-8. PubMed ID: 3144995
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.